Skip to main content
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. — Investor Relations & Filings

Ticker · LNTH ISIN · US5165441032 LEI · 5299005HUB5IOJGO7S39 US Manufacturing
Open in API
Filings indexed 1,029 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US LNTH

About Lantheus Holdings, Inc.

https://www.lantheus.com/

Lantheus Holdings, Inc. is a leading company focused on radiopharmaceuticals, specializing in the development, manufacturing, and commercialization of precision diagnostic and therapeutic products. Its portfolio is designed to assist clinicians in the diagnosis, treatment, and monitoring of various diseases. The company provides diagnostic imaging agents, targeted radiotherapeutics, and leverages artificial intelligence solutions to enhance clinical decision-making. Lantheus's strategy is centered on a 'Find, Fight, and Follow' approach to patient care, aiming to improve outcomes by delivering critical information throughout the disease management process.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 96% confidence The document is an SEC Form SD “Specialized Disclosure Report” regarding Conflict Minerals, filed under Rule 13p-1. It is a regulatory compliance filing and does not itself contain full financial statements or meeting materials, nor does it announce vote results or any of the other specified categories. It falls under the fallback “Regulatory Filings” category.
2026-05-29 English
10-Q - Lantheus Holdings, Inc. (0001521036) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - Lantheus Holdings, Inc. (0001521036) (Filer)
Earnings Release Classification · 92% confidence The document is a Form 8-K current report dated May 7, 2026 filed under Item 2.02 “Results of Operations and Financial Condition,” which furnishes a press release announcing the company’s first quarter 2026 financial results. No full interim financial statements are included—only the initial earnings announcement via press release—so this corresponds to an Earnings Release rather than a full interim report or other category. Q1 2026
2026-05-07 English
8-K - Lantheus Holdings, Inc. (0001521036) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes detailed voting results from the Annual Meeting of Shareholders, including election of directors, approval of executive compensation, amendments to the certificate of incorporation, and approval of an equity incentive plan. It also includes information about the ratification of the appointment of the independent auditor. The document is not a full annual report or financial statement but rather a report on shareholder meeting outcomes and corporate governance changes. The presence of detailed voting results and shareholder meeting matters aligns with the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is sufficient and contains substantive voting data, not just an announcement of a report. Therefore, the best classification is DVA with high confidence.
2026-05-01 English
SCHEDULE 13G/A - Lantheus Holdings, Inc. (0001521036) (Subject)
Major Shareholding Notification
2026-03-27 English
ARS - Lantheus Holdings, Inc. (0001521036) (Filer)
Annual Report
2026-03-20 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.